Study at a glance
What did animal studies test about vitamin D and pain sensitivity?
Two small animal studies tested whether severe vitamin D deficiency changes sensitivity to pressure and features of nerve or immune cells. One used female rats; the other used male and female mice. An animal pulling away from a stimulus is not the same as a person reporting pain. Neither study tested whether supplements relieve chronic pain in people.
How did low vitamin D affect pressure sensitivity in rats?
Deficient rats became more sensitive to calf pressure and had more staining for certain small sensory nerve fibres in muscle. Skin sensitivity and skin nerve patterns did not change in the same way. Blood calcium was similar between groups at four weeks, and the examined muscle did not show immune cells moving into it. The extra nerve growth and sensitivity occurred together, but the study did not prove that one caused the other or demonstrate an inflammatory cause.
What changed in mice and brain immune cells grown in the laboratory?
Deficient adult mice withdrew their paws from lighter pressure. Some spinal-cord immune cells, called microglia, had altered appearances. Microglia grown in the laboratory from their offspring showed several stress-related changes. Vitamin D compounds reduced some abnormalities in the cells grown in the laboratory, but not every measured change. These cells came from different animals from those used for adult behaviour testing. The findings therefore did not prove that the cell changes directly caused pain.
Do these animal findings show pain relief from vitamin D?
Groups were very small. A significant finding in females but not males did not prove a true difference between sexes. A separate rat-cell experiment also found that nerve growth did not increase steadily with active vitamin D concentration. Neither animal study demonstrated pain relief by giving vitamin D to the tested adults. These findings suggest research questions, not a human pain treatment, dose or blood target.
Read the full article below ↓Vitamin D deficiency altered mechanical sensitivity in two small rodent studies, alongside changes in sensory nerve fibres or microglia. These findings identify possible routes to altered pain signalling. They do not establish that vitamin D supplements relieve chronic pain in people. This appraisal separates the animal behaviour, cellular observations and proposed mechanisms. For the shorter account, read Vitamin D, Neural Inflammation and Pain Sensitivity: Study Summary.
Two experiments, two levels of sensory biology
Tague and colleagues examined muscle sensitivity and peripheral innervation in vitamin-D-deficient rats. Alessio and colleagues studied mechanical withdrawal responses in adult mice and microglial features in both adult tissue and cultures derived from pups. Microglia are resident immune cells of the central nervous system. The studies address different parts of the sensory system, rather than repeating one experiment or demonstrating a single complete causal pathway.
The distinction matters within the broader account of vitamin D and nerves. Nerve repair, the number of sensory endings and the sensitivity of an animal to a stimulus are separate outcomes. More nerve fibres need not mean healthier nerves: excessive growth in a particular compartment could accompany heightened sensitivity. Equally, a withdrawal response is an observable behaviour, not a report of the unpleasant experience that defines human pain.
The rat experiment: deficiency before overt structural damage
Tague’s study used fifteen female rats that had undergone removal of the ovaries, with five animals randomly assigned to each diet. The groups received normal vitamin D, vitamin D deficiency with ordinary calcium and phosphorus, or deficiency with increased calcium and phosphorus. The intervention lasted four weeks. Diet coding and blinded assessment reduced some opportunities for observer bias, but the small groups and restricted animal population limit generalisation.
By week four, mean serum 25-hydroxyvitamin D was 70.8 nmol/L in controls, compared with 4.2 and 6.6 nmol/L in the two deficient groups. Serum calcium was similar across groups at that time. The investigators did not find the overt muscle or growth-plate abnormalities they examined. This supports studying sensory effects before those particular structural changes appear; it does not exclude every subtle metabolic or skeletal abnormality.
The investigators applied increasing pressure to the calf and recorded the force at withdrawal. The deficient group receiving more calcium and phosphorus became hypersensitive earlier, at two weeks; the other deficient group showed the effect by four weeks. This comparison cannot isolate calcium from phosphorus because both were increased. It also does not establish that calcium intake generally worsens pain in humans.
Sensitivity to stimulation of the skin did not change in the same way, and topical skin anaesthesia did not remove the calf response difference. Grip strength and general activity were not reduced, although deficient animals failed to show the controls’ improvement on a balance task. These contrasts help localise the observed phenotype, but they do not identify a unique molecular cause or explain every aspect of behaviour.
Sensory sprouting and the limits of an inflammation explanation
Muscle staining showed an approximately twofold increase in the area density of fibres labelled with peripherin, a marker enriched in small sensory fibres, in both deficient groups. This was nerve-fibre area divided by the sampled muscle area, not a count of individual fibres. Fibres containing calcitonin gene-related peptide also increased on average, but the reported significant comparison was in the high-calcium-and-phosphorus group. Sympathetic fibres, large myelinated fibres and motor endplates did not show the same pattern. Skin innervation was also unchanged.
This selectivity is more informative than simply saying that deficiency increased nerves. The altered compartment was muscle sensory innervation. However, the study did not experimentally remove the extra fibres and show that hypersensitivity disappeared. Co-occurrence therefore supports a possible relationship between sprouting and sensitivity without proving that one fully caused the other. The absence of immune-cell infiltration in the examined muscle also argues against describing tissue inflammation as an observed explanation.
The authors discussed neurogenic inflammation, in which sensory nerve activity can influence local inflammatory responses. That remains a proposed mechanism here. The site’s account of inflammatory signalling provides background, but it should not replace the missing causal experiment. A mechanistic claim would be stronger if blocking the proposed mediator changed sensitivity while leaving other relevant processes appropriately controlled.
Cultured sensory neurons showed a non-linear response
In a separate culture experiment, sensory neurons from six-week-old female rats were exposed to different concentrations of calcitriol, the active vitamin D hormone. Small-fibre outgrowth was greatest around 20 picomolar, rather than increasing continuously across the tested range. At that concentration, neurite area per viable neuron was about sixty per cent greater than at zero, sixty or one hundred picomolar. A neurite is a projection growing from a neuron.
A compound designed to favour a rapid vitamin D receptor response produced a similar pattern. Together with receptor localisation, this implicated a receptor-related mechanism, but did not establish it as conclusively as a selective genetic experiment might. The discussion of vitamin D receptors helps explain why cellular responsiveness matters as well as circulating concentration. The culture findings do not define an optimal blood level for people.
The sympathetic-neuron comparison also requires care. Those cells came from newborn animals and were cultured for a different duration, whereas the sensory cultures came from older rats. Cell identity, developmental age and culture conditions therefore differed together. Replicate wells strengthen technical repeatability, but should not be mistaken for the same number of independently exposed animals. Neither this culture experiment nor the dietary rat study tested whether giving deficient animals vitamin D relieved their hypersensitivity.
The mouse study separated adult behaviour from pup-derived cells
Alessio’s investigators randomly assigned male and female mice to diets containing 1,500 or less than 5 international units of vitamin D per kilogram of feed, with calcium and phosphorus otherwise matched. Exposure began three weeks before mating and continued throughout the experiment. Adult parents underwent behavioural testing one week after delivery and then tissue examination, while their young offspring supplied cells for culture. The cultured microglia and the adult withdrawal responses therefore came from different experimental populations. They cannot be joined as if one animal had been followed from an abnormal cell measurement to later pain.
The adult behavioural comparison included only three mice per sex and diet group. Female paw-withdrawal thresholds were 0.05 ± 0.01 g in deficient animals versus 1.3 ± 0.16 g in controls; male values were 0.23 ± 0.18 versus 0.93 ± 0.17 g. These are means with standard errors of the mean, which describe uncertainty in the estimated mean rather than variation among individual animals. Lower thresholds indicate withdrawal to a lighter mechanical stimulus. Serum vitamin D was markedly lower in the deficient groups. These findings support altered mechanical responsiveness under the tested conditions, with considerable uncertainty from the small sample.
Microglia were classified by their appearance in stained tissue. In the spinal cord, the proportion classified as activated was 48.71 ± 7.91% in deficient females versus 10.43 ± 1.41% in controls. Male values were 23.7 ± 10.21% versus 10.36 ± 5.41%, again means with standard errors. The analysis used two-way analysis of variance and Tukey comparisons. The female comparison was significant, whereas the male comparison was not; the diet-by-sex interaction was also not significant, with P = 0.114. A significant result in one sex and a non-significant result in the other does not itself demonstrate a sex difference. Treating those two significance labels as an interaction would overstate the evidence.
Selected brain regions instead showed more cells classified as dystrophic, with fragmented processes and altered cell bodies, particularly in females. This was a morphological classification, not a direct measure of cognitive impairment. The regional findings belong within the wider brain evidence, while the central question here remains sensory modulation. Morphology alone cannot establish a precise inflammatory programme, cytokine profile or causal contribution to withdrawal behaviour.
What the microglial cultures do and do not establish
Microglia obtained from pups exposed to the deficient diet environment showed altered shape, increased Ki67 labelling associated with cell proliferation, and increased intracellular reactive-oxygen signals. The cultures were prepared from pooled pups in three experimental sets from different dams or broods, with technical duplicates. Individual wells or cells are consequently not equivalent to independently randomised animals. The paper reports blinded cellular and tissue evaluations, an important safeguard alongside this limitation.
Exposure to vitamin D metabolites or palmitoylethanolamide, a separate lipid mediator, reduced several culture abnormalities. The tested concentration was 100 nanomolar for twenty-four hours. These were cell exposures, not an oral treatment trial in the adults. Moreover, an increased DNA-damage-response marker, ATM, was not reduced by these treatments. Cell viability and the measured apoptotic and necrotic fractions were not significantly altered, so the results should not be summarised as uniform cellular rescue.
Beta-galactosidase staining also increased and was reduced by the culture treatments. Although often used as a senescence-associated marker, this finding alone cannot establish irreversible cellular senescence. The authors themselves discuss cellular stress as another interpretation. The supplementary cell-cycle plot did not establish a significant redistribution between phases. These distinctions prevent a collection of laboratory markers from becoming a stronger claim about ageing, inflammation or recovery than the experiment supports.
Connecting the findings without turning them into treatment advice
The rat and mouse findings make altered sensory regulation a plausible research question. They do not establish one shared mechanism across species, tissues or pain conditions. The concept of neuroendocrine integration helps frame communication between hormonal and neural systems, but neither study measured a complete endocrine-to-immune-to-behaviour sequence. The relevant links remain hypotheses requiring experiments designed to test mediation.
It is also necessary to distinguish vitamin D status from vitamin D effect. Severe dietary depletion, exposure to active hormone in a dish and treatment of a person with chronic pain are different interventions. A deficiency model can reveal a vulnerability without showing that supplements reverse an established clinical condition. Neither study supplies a human treatment dose, a pain-specific blood target or evidence that all forms of pain respond alike.
Within the evidence hierarchy, these experiments provide mechanistic leads and controlled animal comparisons. A clinical claim would require appropriately designed human studies with defined pain conditions, baseline status, meaningful patient outcomes and adequate follow-up. More decisive mechanistic work would also test reversal and selectively manipulate the proposed sensory or microglial pathway. Until then, the defensible conclusion is altered experimental sensitivity with several plausible biological explanations, rather than proven pain relief.
Scientific sources
Tague SE, Clarke GL, Winter MK, McCarson KE, Wright DE, Smith PG. Vitamin D Deficiency Promotes Skeletal Muscle Hypersensitivity and Sensory Hyperinnervation. Journal of Neuroscience. 2011;31:13728 to 13738. DOI:10.1523/JNEUROSCI.3637-11.2011. PMID:21957236. Complete principal paper, seven figures and two tables examined.
Alessio N, Belardo C, Trotta MC, et al. Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice. International Journal of Molecular Sciences. 2021;22:3604. DOI:10.3390/ijms22073604. PMID:33808491. Complete principal paper, six figures, experimental scheme and supplementary cell-cycle figure examined.
Related reading
Post-stroke sarcopenia as a neuromuscular disorder: a mini review of neural mechanisms and clinical implications
Post-stroke sarcopenia represents a distinct neuromuscular disorder characterized by progressive muscle loss and functional decline.
Original paper ↗Read more →Vitamin D, Neural Inflammation and Pain Sensitivity: Study Summary
Understand the evidence linking vitamin D deficiency, sensory changes and neural inflammation, including why animal pain findings do not prove treatment benefit.
Read more →A high calcium diet containing nonfat dry milk reduces weight gain and associated adipose tissue inflammation in diet-induced obese mice when compared to high calcium alone
Mice fed high-Ca + NFDM had reduced body weight and adiposity compared to high-Ca mice (P < 0.001).
Original paper ↗Read more →Association of 25(OH)D status with calcium metabolism, inflammation, and thyroid autoimmunity in patients with type 2 diabetes mellitus
This study aimed to investigate the clinical associations of serum 25(OH)D levels with calcium metabolism, inflammation, thyroid function, and autoimmunity in patients with T2DM.
Original paper ↗Read more →Frailty in Older Adults with Severe Aortic Stenosis: The Role of Systemic Inflammation and Calcium Homeostasis
This study aimed to analyze systemic inflammation and calcium homeostasis biomarkers and their associations with frailty in older adults with severe AoS.
Original paper ↗Read more →Target Values for 25-Hydroxy and 1,25-Dihydroxy Vitamin D Based on Their Associations with Inflammation and Calcium-Phosphate Metabolism
Target values for 25-hydroxy vitamin D and 1,25(OH)2D or 1,25-dihydroxy vitamin D remain a topic of debate among clinicians.
Original paper ↗Read more →The effects of magnesium-zinc-calcium-vitamin D co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes
This study was aimed to determine the effects of magnesium-zinc-calcium-vitamin D co-supplementation on parameters of inflammation and oxidative stress, and pregnancy outcomes among women with GDM.
Original paper ↗Read more →Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo
Recently, nanomaterials have emerged as a tool in developing novel therapies against inflammatory diseases.
Original paper ↗Read more →Lung Inflammation Induced by Inactivated SARS-CoV-2 in C57BL/6 Female Mice Is Controlled by Intranasal Instillation of Vitamin D
The COVID-19 pandemic was triggered by the coronavirus SARS-CoV-2, whose peak occurred in the years 2020 and 2021.
Original paper ↗Read more →Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection
Vitamin D induces a diverse range of biological effects, including important functions in bone health, calcium homeostasis and, more recently, on immune function.
Original paper ↗Read more →Inflammation, oxidative stress, matrix metalloproteinases and DNA damage in diabetic polyneuropathy and neuropathic pain
This study aimed to investigate the associations between inflammation, oxidative stress, matrix metalloproteinases (MMPs), DNA damage, and the presence of distal symmetric diabetic polyneuropathy (DPNP) and diabetic neuropathic pain (DNP).
Original paper ↗Read more →Proteomics Analysis Reveals Serum Biomarkers Reflecting Joint Pain and Physical Limitations in Knee Osteoarthritis Before and After Joint Replacement Surgery
This study aimed to identify serum proteins that could indicate the occurrence of knee OA (KOA) and correlate with patients’ pain and functional impairment.
Original paper ↗Read more →Vitamin D as a modulator of pain and inflammation in postmenopausal females with burning mouth syndrome
The aim of this study was to investigate relationship between vitamin D levels and clinical features in postmenopausal females with burning mouth syndrome (BMS).
Original paper ↗Read more →A molecular systems architecture of asthma
Asthma is a heterogeneous inflammatory disease driven by complex genetic, immunological, environmental, and neuro-immune interactions.
Original paper ↗Read more →CYP11A1 Upregulation Leads to Trophoblast Oxidative Stress and Fetal Neurodevelopmental Toxicity That can be Rescued by Vitamin D
During normal pregnancy, the placental trophoblast secretes a variety of steroid hormones and participates in the regulation of maternal physiological functions and fetal development.
Original paper ↗Read more →Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure
Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease (CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear.
Original paper ↗Read more →Efficacy of Danshen injection combined with Calcitriol and Calcium/Vitamin-D for the treatment of osteoporotic fractures: A retrospective case-control study
To explore the efficacy of Danshen injection combined with calcitriol and calcium/Vitamin-D in the treatment of osteoporotic fractures.
Original paper ↗Read more →Macrophages in obesity are characterised by increased IL-1β response to calcium-sensing receptor signals
We hypothesised, that this mechanism might contribute to the activation of adipose tissue (AT) in obesity, and investigated [Ca2+]ex-induced, CaSR mediated IL-1β release by macrophages in obesity.
Original paper ↗Read more →Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity
Since IL-34 is critical to the homeostasis of microglia, and was previously shown to be induced in endothelial cells by vitamin D, we investigated IL-34 as the potential anti-inflammatory molecule induced in neurons by vitamin D.
Original paper ↗Read more →Visualized knowledge mapping on the current research trends and emerging areas of neuroimmune modulation in the past two decades
Reference data analysis and visualization methods were applied to identify current knowledge mapping methods in the neuroimmune modulation research field.
Original paper ↗Read more →25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor
In this study, we aimed to evaluate changes in liver NK cells cytotoxicity due to modulations in VDR in CCl4 fibrosis model following 25(OH) D3 injections.
Original paper ↗Read more →Original sources
Vitamin D Deficiency Promotes Skeletal Muscle Hypersensitivity and Sensory Hyperinnervation
Published in Journal of Neuroscience (2011).
Publication details
Tague SE, Clarke GL, Winter MK, McCarson KE, Wright DE, Smith PG. Vitamin D Deficiency Promotes Skeletal Muscle Hypersensitivity and Sensory Hyperinnervation. Journal of Neuroscience. 2011;31:13728 to 13738. DOI:10.1523/JNEUROSCI.3637-11.2011. PMID:21957236. Complete principal paper, seven figures and two tables examined.
Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice
Published in International Journal of Molecular Sciences (2021).
Publication details
Alessio N, Belardo C, Trotta MC, et al. Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice. International Journal of Molecular Sciences. 2021;22:3604. DOI:10.3390/ijms22073604. PMID:33808491. Complete principal paper, six figures, experimental scheme and supplementary cell-cycle figure examined.